MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PFE has $208,160M in assets. $121,385M in debts. $1,142M in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
115.99%
Quick Ratio
87.18%
Cash Ratio
3.09%
Debt to Asset Ratio
58.31%
Unit: Million (M) dollars
Assets Breakdown
    • Goodwill
    • Short-term investments
    • Trade accounts receivable, net o...
    • Others
Liabilities Breakdown
    • Treasury stock, shares at cost 2...
    • Retained earnings
    • Additional paid-in capital
    • Others

Balance Sheets
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
1,142 1,043 2,853 416
Equity securities with readily determinable fair values
-7,848 --
Available-for-sale debt securities
-10,881 --
Held-to-maturity debt securities
-705 --
Short-term investments
12,454 19,434 9,837 22,316
Trade accounts receivable, net of allowance for doubtful accounts 2025427 2024438
11,874 11,463 11,177 10,952
Inventories
10,654 10,851 10,189 8,981
Current tax assets
3,967 3,314 3,978 3,577
Other current assets
2,808 4,253 5,299 5,017
Total current assets
42,898 50,358 43,333 51,259
Equity-method investments
-217 11,637 11,033
Long-term investments
1,621 2,010 3,731 4,036
Property, plant and equipment, net
19,317 18,393 18,940 16,274
Finite-lived intangible assets, gross carrying amount
-103,397 -88,763
Finite-lived intangible assets, accumulated amortization
-67,549 -58,548
Finite-lived intangible assets, net
-35,848 -30,215
Total indefinite-lived intangible assets
-19,563 -13,155
Identifiable intangible assets, net
53,731 55,411 64,900 43,370
Goodwill
71,264 68,527 67,783 51,375
Noncurrent deferred tax assets and other noncurrent tax assets
9,699 8,662 3,706 6,693
Other noncurrent assets
9,631 9,817 12,471 13,163
Total assets
208,160 213,396 226,501 197,205
Short-term borrowings, including current portion of long-term debt 20252,997 20243,747
3,154 6,946 10,350 2,945
Trade accounts payable
5,240 5,633 6,710 6,809
Dividends payable
2,445 2,437 2,372 2,303
Income taxes payable
3,103 2,910 2,349 1,587
Accrued compensation and related items
3,610 3,838 2,776 3,407
Deferred revenues
784 1,511 2,700 2,520
Other current liabilities
18,648 19,720 20,537 22,568
Total current liabilities
36,984 42,995 47,794 42,138
Long-term debt
61,641 57,405 61,538 32,884
Pension and postretirement benefit obligations
2,041 2,115 2,167 2,250
Noncurrent deferred tax liabilities
2,401 2,122 640 1,023
Other taxes payable
3,591 6,112 8,534 9,812
Other noncurrent liabilities
14,725 14,150 16,539 13,180
Total liabilities
121,385 124,899 137,213 101,288
Preferred stock, no par value, at stated value 27 shares authorized no shares issued or outstanding as of december 31, 2023 and december 31, 2022
--0 0
Common stock, 0.05 par value 12,000 shares authorized issued 20259,621 20249,593
481 480 478 476
Additional paid-in capital
94,469 93,603 92,631 91,802
Treasury stock, shares at cost 20233,916 20223,903
--114,487 113,969
Treasury stock, shares at cost 20253,935 20243,926
115,015 114,763 --
Retained earnings
114,610 116,725 118,353 125,656
Accumulated other comprehensive loss
-8,069 -7,842 -7,961 -8,304
Total pfizer inc. shareholders equity
86,476 88,203 89,014 95,661
Equity attributable to noncontrolling interests
299 294 274 256
Total equity
86,775 88,497 89,288 95,916
Total liabilities and equity
208,160 213,396 226,501 197,205
Unit: Million (M) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$12,454M (-35.92%↓ Y/Y)Trade accountsreceivable, net of allowance...$11,874M (3.59%↑ Y/Y)Inventories$10,654M (-1.82%↓ Y/Y)Current tax assets$3,967M (19.70%↑ Y/Y)Other current assets$2,808M (-33.98%↓ Y/Y)Cash and cashequivalents$1,142M (9.49%↑ Y/Y)Goodwill$71,264M (3.99%↑ Y/Y)Identifiable intangibleassets, net$53,731M (-3.03%↓ Y/Y)Total current assets$42,898M (-14.81%↓ Y/Y)Property, plant andequipment, net$19,317M (5.02%↑ Y/Y)Noncurrent deferred taxassets and other...$9,699M (11.97%↑ Y/Y)Other noncurrentassets$9,631M (-1.89%↓ Y/Y)Long-term investments$1,621M (-19.35%↓ Y/Y)Total assets$208,160M (-2.45%↓ Y/Y)Total liabilities andequity$208,160M (-2.45%↓ Y/Y)Total liabilities$121,385M (-2.81%↓ Y/Y)Total equity$86,775M (-1.95%↓ Y/Y)Long-term debt$61,641M (7.38%↑ Y/Y)Total currentliabilities$36,984M (-13.98%↓ Y/Y)Other noncurrentliabilities$14,725M (4.06%↑ Y/Y)Other taxes payable$3,591M (-41.25%↓ Y/Y)Noncurrent deferred taxliabilities$2,401M (13.15%↑ Y/Y)Pension andpostretirement benefit...$2,041M (-3.50%↓ Y/Y)Total pfizer inc.shareholders equity$86,476M (-1.96%↓ Y/Y)Equity attributable tononcontrolling interests$299M (1.70%↑ Y/Y)Treasury stock, shares atcost 20253,935...$115,015M (0.22%↑ Y/Y)Accumulated othercomprehensive loss-$8,069M (-2.89%↓ Y/Y)Other currentliabilities$18,648M (-5.44%↓ Y/Y)Trade accountspayable$5,240M (-6.98%↓ Y/Y)Accrued compensationand related items$3,610M (-5.94%↓ Y/Y)Short-term borrowings,including current portion...$3,154M (-54.59%↓ Y/Y)Income taxes payable$3,103M (6.63%↑ Y/Y)Dividends payable$2,445M (0.33%↑ Y/Y)Deferred revenues$784M (-48.11%↓ Y/Y)Retained earnings$114,610M (-1.81%↓ Y/Y)Additional paid-in capital$94,469M (0.93%↑ Y/Y)Common stock, 0.05 parvalue 12,000 shares...$481M (0.21%↑ Y/Y)

Pfizer_(2021)-svg

PFIZER INC (PFE)

Pfizer_(2021)-svg

PFIZER INC (PFE)